HPC
ABMD

HM Payson & Co’s Abiomed Inc ABMD Stock Holding History

HM Payson & Co’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-256
Closed -$63K – 1016
2022
Q3 		$63K Hold
256
– – ﹤0.01% 542
2022
Q2 		$63K Hold
256
– – ﹤0.01% 547
2022
Q1 		$85K Hold
256
– – ﹤0.01% 522
2021
Q4 		$92K Sell
256
-31
-11% -$10.5K ﹤0.01% 509
2021
Q3 		$93K Sell
287
-36
-11% -$12.2K ﹤0.01% 494
2021
Q2 		$101K Sell
323
-183
-36% -$56.1K ﹤0.01% 480
2021
Q1 		$161K Buy
506
+500
+8,333% +$160K ﹤0.01% 424
2020
Q4 		$2K Hold
6
– – ﹤0.01% 1037
2020
Q3 		$2K Buy
+6
New +$1.73K ﹤0.01% 969

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HM Payson & Co's ABMD Position: Q4 2022 in Review

HM Payson & Co sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 256 shares — an estimated $63K sold.

HM Payson & Co first reported a position in ABMD in Q3 2020 and held it in 9 quarters. The position peaked at $161K in Q1 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • HM Payson & Co reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • HM Payson & Co sold 256 Abiomed Inc shares in Q4 2022, an estimated $63K.
  • HM Payson & Co first reported a position in Abiomed Inc in Q3 2020 and held it in 9 quarters.
  • HM Payson & Co's Abiomed Inc position peaked at $161K in Q1 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on HM Payson & Co's 13F filing for Q4 2022, filed 6 Feb 2023.